Search research articles
Contact Us
Filters
Showing results (291-300 of 720) with videos related to
Page
of 72
Sort By:
Neuroscience
|
July 22, 2008
Contributions of the amygdala and medial prefrontal cortex to incentive cue responding
A Ishikawa, F Ambroggi, S M Nicola, et al.
Brain Research
|
March 18, 1982
Lumbar intrathecal naloxone blocks analgesia produced by microstimulation of the ventromedial medulla in the rat
G Zorman, G Belcher, J E Adams, et al.
Plos One
|
February 25, 2012
Cell-type specific oxytocin gene expression from AAV delivered promoter deletion constructs into the rat supraoptic nucleus in vivo
Raymond L Fields, Todd A Ponzio, Makoto Kawasaki, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
May 9, 2008
Dorsomedial prefrontal cortex contribution to behavioral and nucleus accumbens neuronal responses to incentive cues
Akinori Ishikawa, Frederic Ambroggi, Saleem M Nicola, et al.
Clinical Chemistry
|
April 1, 1985
Factors affecting the binding of disopyramide to serum proteins
L M Shaw, R Altman, B C Thompson, et al.
Journal of Interpersonal Violence
|
December 30, 2021
Domestic Violence Survivorship Among a Sample of Older African American Women: An Interpretative Phenomenological Analysis
Jacqueline Burse, Rachel Voth-Schrag, Noelle L Fields, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1975
New cell surface antigens in rat defined by tumors of the nervous system
K L Fields, C Gosling, M Megson, et al.
Neuron
|
September 2, 2008
Basolateral amygdala neurons facilitate reward-seeking behavior by exciting nucleus accumbens neurons
Frederic Ambroggi, Akinori Ishikawa, Howard L Fields, et al.
The Journal of Comparative Neurology
|
February 10, 1997
GABA-immunoreactive boutons contact identified OFF and ON cells in the nucleus raphe magnus
K Skinner, H L Fields, A I Basbaum, et al.
Therapeutic Drug Monitoring
|
December 1, 1993
The use of concentration measurements of parent drug and metabolites during clinical trials
L M Shaw, H S Bonner, L Fields, et al.
Page
of 72
Search research articles
Search
Showing results (291-300 of 720) with videos related to
Sort By:
Page
of 72
Neuroscience
|
July 22, 2008
Contributions of the amygdala and medial prefrontal cortex to incentive cue responding
A Ishikawa, F Ambroggi, S M Nicola, et al.
Brain Research
|
March 18, 1982
Lumbar intrathecal naloxone blocks analgesia produced by microstimulation of the ventromedial medulla in the rat
G Zorman, G Belcher, J E Adams, et al.
Plos One
|
February 25, 2012
Cell-type specific oxytocin gene expression from AAV delivered promoter deletion constructs into the rat supraoptic nucleus in vivo
Raymond L Fields, Todd A Ponzio, Makoto Kawasaki, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
May 9, 2008
Dorsomedial prefrontal cortex contribution to behavioral and nucleus accumbens neuronal responses to incentive cues
Akinori Ishikawa, Frederic Ambroggi, Saleem M Nicola, et al.
Clinical Chemistry
|
April 1, 1985
Factors affecting the binding of disopyramide to serum proteins
L M Shaw, R Altman, B C Thompson, et al.
Journal of Interpersonal Violence
|
December 30, 2021
Domestic Violence Survivorship Among a Sample of Older African American Women: An Interpretative Phenomenological Analysis
Jacqueline Burse, Rachel Voth-Schrag, Noelle L Fields, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1975
New cell surface antigens in rat defined by tumors of the nervous system
K L Fields, C Gosling, M Megson, et al.
Neuron
|
September 2, 2008
Basolateral amygdala neurons facilitate reward-seeking behavior by exciting nucleus accumbens neurons
Frederic Ambroggi, Akinori Ishikawa, Howard L Fields, et al.
The Journal of Comparative Neurology
|
February 10, 1997
GABA-immunoreactive boutons contact identified OFF and ON cells in the nucleus raphe magnus
K Skinner, H L Fields, A I Basbaum, et al.
Therapeutic Drug Monitoring
|
December 1, 1993
The use of concentration measurements of parent drug and metabolites during clinical trials
L M Shaw, H S Bonner, L Fields, et al.
Page
of 72